Source link : https://newshealth.biz/health-news/fda-oks-new-drug-for-lung-cancer-with-c-met-overexpression/
(MedPage Today) — The FDA granted accelerated approval to telisotuzumab vedotin (Emrelis) for the treatment of adults with previously treated, locally advanced, or metastatic non-squamous non-small cell lung cancer (NSCLC) with high c-Met protein… Source link : https://www.medpagetoday.com/hematologyoncology/lungcancer/115586 Author : Publish date : 2025-05-14 20:48:00 Copyright for syndicated content belongs to the linked Source.
The post FDA OKs New Drug for Lung Cancer With c-Met Overexpression first appeared on News Health.
—-
Author : News Health
Publish date : 2025-05-14 20:48:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8